Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2004 1
2005 1
2006 2
2007 2
2008 7
2009 12
2010 5
2011 3
2012 4
2013 3
2014 2
2015 2
2016 1
2019 1
2020 2
2021 1
2022 3
2024 3
2025 4

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

50 results

Results by year

Filters applied: . Clear all
Page 1
PD-L1 imaging with [99mTc]NM-01 SPECT/CT is associated with metabolic response to pembrolizumab with/without chemotherapy in advanced lung cancer.
Hughes DJ, Chand G, Johnson J, Tegala R, Bailey D, Adamson K, Edmonds S, Meszaros LK, Moore AEB, Manickavasagar T, Ndagire S, Gennatas S, Georgiou A, Ghosh S, Josephs D, Karapanagiotou E, McLean E, Ting HH, Spicer J, Goh V, Cook GJR. Hughes DJ, et al. Among authors: karapanagiotou e. Br J Cancer. 2025 Apr 5. doi: 10.1038/s41416-025-02991-w. Online ahead of print. Br J Cancer. 2025. PMID: 40188291
A Retrospective Evaluation of PD-L1 Expression and Heterogeneity in Early-Stage Non-Small Cell Lung Cancer (REPLICA).
Josephides EC, Smith D, Bille A, Patel A, Rush HL, Dunn R, Hughes DJ, Hunter S, Taniere P, Crawley D, Monroy-Iglesias M, Henry AR, Montes A, Van Hemelrijck M, Spicer J, Josephs D, Santis G, Nonaka D, Karapanagiotou EM. Josephides EC, et al. Among authors: karapanagiotou em. Clin Lung Cancer. 2025 May;26(3):e223-e231. doi: 10.1016/j.cllc.2025.01.008. Epub 2025 Jan 13. Clin Lung Cancer. 2025. PMID: 39915192
Determinants of 5-year survival in patients with advanced NSCLC with PD-L1≥50% treated with first-line pembrolizumab outside of clinical trials: results from the Pembro-real 5Y global registry.
Cortellini A, Brunetti L, Di Fazio GR, Garbo E, Pinato DJ, Naidoo J, Katz A, Loza M, Neal JW, Genova C, Gettinger S, Kim SY, Jayakrishnan R, El Zarif T, Russano M, Pecci F, Di Federico A, Awad M, Alessi JV, Montrone M, Owen DH, Signorelli D, Fidler MJ, Li M, Camerini A, De Giglio A, Young L, Vincenzi B, Metro G, Passiglia F, Yendamuri S, Guida A, Ghidini M, Awosika NO, Napolitano A, Fulgenzi CAM, Grisanti S, Grossi F, D'Incecco A, Josephides E, Van Hemelrijck M, Russo A, Gelibter A, Spinelli G, Verrico M, Tomasik B, Giusti R, Newsom-Davis T, Bria E, Sebastian M, Rost M, Forster M, Mukherjee U, Landi L, Mazzoni F, Aujayeb A, Dupont M, Curioni-Fontecedro A, Chiari R, Pantano F, Morabito A, Leonetti A, Friedlaender A, Addeo A, Zoratto F, De Tursi M, Cantini L, Roca E, Mountzios G, Della Gravara L, Kalvapudi S, Inno A, Bironzo P, Di Marco Barros R, O'Reilly D, Bell J, Karapanagiotou E, Monnet I, Baena J, Macerelli M, Majem M, Agustoni F, Cortinovis DL, Tonini G, Minuti G, Bennati C, Mezquita L, Gorría T, Servetto A, Beninato T, Lo Russo G, Rogado J, Moliner L, Biello F, Aboubakar Nana F, Dingemans AM, Aerts JGJV, Ferrara R, Torri V, Hejleh TA, Takada K, Naqash AR, Garassino M, … See abstract for full author list ➔ Cortellini A, et al. Among authors: karapanagiotou e. J Immunother Cancer. 2025 Feb 4;13(2):e010674. doi: 10.1136/jitc-2024-010674. J Immunother Cancer. 2025. PMID: 39904562 Free PMC article.
Hydroxychloroquine in combination with platinum doublet chemotherapy as first-line treatment for extensive-stage small cell lung cancer (Study 15): A randomised phase II multicentre trial.
Lee SM, Hewish M, Ahmed S, Papadatos-Pastos D, Karapanagiotou E, Blackhall F, Ford A, Young R, Garcia A, Arora A, Hollingdale A, Ahmad T, Forster M, Greystoke A, Bremner F, Rudd R, Farrelly L, Vaja S, Hackshaw A. Lee SM, et al. Among authors: karapanagiotou e. Eur J Cancer. 2025 Jan 17;215:115162. doi: 10.1016/j.ejca.2024.115162. Epub 2024 Dec 6. Eur J Cancer. 2025. PMID: 39693892 Free article. Clinical Trial.
Real-World Analysis of Survival and Treatment Efficacy in Stage IIIA-N2 Non-Small Cell Lung Cancer.
Josephides E, Dunn R, Henry AR, Pilling J, Harrison-Phipps K, Patel A, Ahmad S, Skwarski M, Spicer J, Georgiou A, Ghosh S, Van Hemelrijck M, Karapanagiotou E, Smith D, Bille A. Josephides E, et al. Among authors: karapanagiotou e. Cancers (Basel). 2024 Sep 2;16(17):3058. doi: 10.3390/cancers16173058. Cancers (Basel). 2024. PMID: 39272916 Free PMC article.
Predicting programmed death-ligand 1 (PD-L1) expression with fluorine-18 fluorodeoxyglucose ([18F]FDG) positron emission tomography/computed tomography (PET/CT) metabolic parameters in resectable non-small cell lung cancer.
Hughes DJ, Josephides E, O'Shea R, Manickavasagar T, Horst C, Hunter S, Tanière P, Nonaka D, Van Hemelrijck M, Spicer J, Goh V, Bille A, Karapanagiotou E, Cook GJR. Hughes DJ, et al. Among authors: karapanagiotou e. Eur Radiol. 2024 Sep;34(9):5889-5902. doi: 10.1007/s00330-024-10651-5. Epub 2024 Feb 22. Eur Radiol. 2024. PMID: 38388716 Free PMC article.
Non-Small Cell Lung Cancer (NSCLC) in Young Adults, Age < 50, Is Associated with Late Stage at Presentation and a Very Poor Prognosis in Patients That Do Not Have a Targeted Therapy Option: A Real-World Study.
Hughes DJ, Kapiris M, Podvez Nevajda A, McGrath H, Stavraka C, Ahmad S, Taylor B, Cook GJR, Ghosh S, Josephs D, Pintus E, Gennatas S, Bille A, Ryanna K, Santis G, Montes A, Van Hemelrijck M, Karapanagiotou E, Smith D, Spicer J, Georgiou A. Hughes DJ, et al. Among authors: karapanagiotou e. Cancers (Basel). 2022 Dec 9;14(24):6056. doi: 10.3390/cancers14246056. Cancers (Basel). 2022. PMID: 36551542 Free PMC article.
50 results